type here...

CATEGORIES

Public Health

LATEST

1...111213...56Page 12 of 56

TRENDING

EDITORS CHOICE

Artificial Intelligence, Microbiome, and Predicting Liver Disease

Michael Hunter, MD -
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

Infection Control, Physicians’ Offices, and Our Health May Be in Serious Jeopardy

Pat Farrell PhD -
The current state of medicine and consolidation, plus corporate and equity purchases, is causing concern in healthcare

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

Richard Hatzfeld -
This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories